The Institute for Experimental Molecular Imaging (ExMI) at the University Hospital Aachen and the Helmholtz Institute for Biomedical Engineering at RWTH Aachen University is headed by Univ.-Prof. Dr. med. Fabian Kiessling. ExMI focuses on the development of novel contrast agents, imaging techniques and therapeutic approaches to characterize and treat cancer, cardiovascular and inflammatory disorders.ExMI currently consists of two departments and four research groups:


    • Fabian Kiessling has been awarded as fellow of the World Molecular Imaging Society
    • Vertika Pathak has won the “2020 Vevo Travel Award in the Molecular Imaging Category”
    • Yang Shi was awarded by the Controlled Release Society (CRS) with an award for the best on-demand talk on “Targeting innate and adaptive immunity by polymeric nanomedicines”
    • Yang Shi was awarded the Theodore von Kármán Fellowship for Outgoing Scientists
    • Twan Lammers received the 2020 International Award from the Belgian Society for Pharmaceutical Sciences